Search results for "infarct"

showing 10 items of 1223 documents

Combination of clinical risk profile, early exercise testing and circulating biomarkers for evaluation of patients with acute chest pain without ST-s…

2007

Objective: To investigate the combination of clinical data, exercise testing and biomarkers for the evaluation of patients with chest pain without ST-segment deviation or troponin elevation. Design: Prospective cohort design. Settting: Two teaching hospitals in Spain. Patients: 422 patients presenting to the emergency department were studied. Leukocyte count, C-reactive protein (CRP), pregnancy-associated plasma protein A (PAPP-A) and N-terminal pro-brain natriuretic peptide (NTproBNP) were determined. A validated clinical risk score (number of points according to pain characteristics and risk factors) was used for clinical evaluation and early exercise testing was performed. Main outcome m…

Chest Painmedicine.medical_specialtyMyocardial InfarctionPhysical exerciseChest painInternal medicineNatriuretic Peptide BrainmedicineHumansMyocardial infarctionRisk factorProspective cohort studyFramingham Risk Scorebiologybusiness.industryST elevationMiddle Agedmedicine.diseaseTroponinPeptide FragmentsTroponinSurgeryExercise Testbiology.proteinCardiologymedicine.symptomEpidemiologic MethodsCardiology and Cardiovascular MedicinebusinessBiomarkersHeart
researchProduct

Apple Watch detecting coronary ischaemia during chest pain episodes or an apple a day may keep myocardial infarction away

2020

Chest Painmedicine.medical_specialtybusiness.industryMyocardial InfarctionMyocardial IschemiaMEDLINEIschemiaCardiovascular Flashlightsmedicine.diseaseChest painInternal medicineCardiologyHumansMedicineMyocardial infarction diagnosisMyocardial infarctionmedicine.symptomCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct

Low toenail chromium concentration and increased risk of nonfatal myocardial infarction

2005

Chromium intake may increase insulin sensitivity, glucose tolerance, and the ratio of high density lipoprotein cholesterol to low density lipoprotein cholesterol. However, the epidemiologic evidence on the association between chromium and cardiovascular disease is very limited. To determine whether low toenail chromium concentrations were associated with risk of nonfatal myocardial infarction, the authors conducted an incident, population-based, case-control study in eight European countries and Israel in 1991-1992. Cases (n = 684) were men with a first diagnosis of myocardial infarction recruited from the coronary units of participating hospitals. Controls (n = 724) were men selected rando…

ChromiumMaleRiskmedicine.medical_specialtyNutrition and DiseaseEpidemiologyInternational CooperationPopulationMyocardial Infarctioncardiovascular-diseaseChromium deficiencysupplementspicolinateRisk FactorsInternal medicineVoeding en ZiekteEpidemiologymedicineHumansMyocardial infarctionRisk factorglucoseeducationVLAGGlobal Nutritioneducation.field_of_studyWereldvoedingbusiness.industrycoronary-arteryCase-control studyweightOdds ratioNeutron Activation AnalysisMiddle AgedToesmedicine.diseaseConfidence intervalSurgerynutritionNailsCase-Control StudiesdietaryatherosclerosisbusinessmetaanalysisAmerican Journal of Epidemiology
researchProduct

Ischemic cardiovascular disease in workers occupationally exposed to urban air pollution – A systematic review

2018

Introduction Cardiovascular disease is the first cause of morbidity and mortality worldwide. Among several known risk factors, researchers also focus their attention on the chronic exposure to air pollution. There is much evidence that exposure to air pollution, especially to ultrafine particles, can damage the endothelium and can favour cardiovascular diseases in the general population. Occupational exposition could be an additive risk factor for the cardiovascular system. This article presents a scientific review of the linkage between occupational exposure to air pollution and ischemic heart disease. Material and methods A scientific review was undertaken, followed by PRISMA Statements. …

Chronic exposuremedicine.medical_specialtyPopulationinfarctionAir pollutionDiseasemedicine.disease_causelcsh:Agriculture03 medical and health sciences0302 clinical medicineIschemiaEnvironmental healthAir PollutionOccupational ExposuremedicineHumans030212 general & internal medicineMyocardial infarctionRisk factorCitiesIntensive care medicineeducationProspective cohort studyWaste Management and DisposalEcology Evolution Behavior and Systematicslcsh:Environmental scienceslcsh:GE1-350education.field_of_studyAir Pollutantsair pollution infarction cardiovascularbusiness.industrycardiovascularSettore MED/44 - Medicina Del LavoroPublic Health Environmental and Occupational Healthlcsh:S030208 emergency & critical care medicinemedicine.diseaseCardiovascular DiseasesObservational studybusiness
researchProduct

Oral Glycoprotein IIb/IIa Antagonists for Unstable Angina — Is There Still a Chance for the Oral Substances?

2001

The intravenous glycoprotein IIb/IIIa antagonists abciximab, tirofiban and eptifibatide are well accepted for the therapy of patients with unstable angina and/or as concomitant medication during coronary interventions. Despite the fact that these drugs are not used in all patients presenting with unstable angina during coronary interventions, the scientific evidence is overwhelming including the substantial reduction in mortality 3 years after utilisation of abciximab for coronary interventions in patients with unstable angina. In addition to these two indications, intravenous glycoprotein IIb/IIIa antagonists are currently being investigated for use in patients undergoing carotid artery in…

Clinical Trials as Topicmedicine.medical_specialtyUnstable anginaFibrinogen receptorbusiness.industryAdministration OralPlatelet Glycoprotein GPIIb-IIIa ComplexHematologyTirofibanmedicine.diseaseAnginaInternal medicinemedicineAbciximabCardiologyEptifibatideHumansAngina UnstableMyocardial infarctionbusinessStrokePlatelet Aggregation Inhibitorsmedicine.drugThrombosis Research
researchProduct

Impact of diabetes mellitus on outcomes in patients with myocardial infarction according to varying degrees of left ventricular systolic dysfunction.

2022

Background: Diabetes mellitus (DM) is known to contribute to unfavorable short- and long-term outcomes in patients with myocardial infarction (MI). Particularly poor outcomes are associated with left ventricular systolic dysfunction after an MI. The aim of our study was to compare the short- and long-term outcomes of MI in patients with DM and varied degrees of left ventricular systolic dysfunction with the corresponding outcomes in a non-diabetic control group. Methods: This analysis focused on patients with MI registered in the Polish National Registry of Acute Coronary Syndrome between 2009 and 2011. For the purposes of this analysis, diabetic patients were additionally stratified into t…

Cohort StudiesVentricular Dysfunction LeftDiabetes MellitusMyocardial Infarctionheart failureHumansRegistriesCardiology and Cardiovascular Medicineejection fractionAgedKardiologia polska
researchProduct

MR imaging of bilateral paramedian thalamic and mesencephalic infarcts: A case report

2010

We describe MR imaging of bilateral infarction of the paramedian portion of the mesencephalus and thalamus due to an occlusion of the Percheron artery. This entity is due to one of the anatomic variants of the perforating arteries supplying the thalamus and mesenchephalus. Clinically this kind of infarction presents with neurologic impairment as a disorder of consciousness, memory dysfunctions, various types of vertical gaze palsy and psychic changes, which need to be differentiated from delirium and coma. At MRI evaluation infarction of the paramedian portion of thalami and midbrain, with a “butterfly wings” pattern, was demonstrated as high signal intensity areas on FLAIR and FSE-T2W ima…

Comamedicine.medical_specialtyPalsybusiness.industryThalamusInfarctionGeneral MedicineAnatomyFluid-attenuated inversion recoverymedicine.diseaseSurgeryMidbrainPerforating arteriesmedicine.arteryOcclusionNONEmedicinePercheron artery MR Brain IschemiaRadiology Nuclear Medicine and imagingcardiovascular diseasesNeurology (clinical)medicine.symptombusiness
researchProduct

Strict compliance with ESC therapeutic guidelines after myocardial infarction treated with invasive strategy correlates with improved 18-month outcom…

2020

Abstract Background Despite improved early outcomes in patients (pts) with acute myocardial infarction (MI) in Poland with prevalent strategy of primary angioplasty by radial access, mid- and long-term outcomes are unsatisfactory. Objective We hypothesized that strict implementation of secondary prevention ESC guidelines in post-infarction management may be related with improved mid-term clinical outcomes Methods We compared 18-month outcomes of pts treated for MI with primary invasive strategy in a tertiary university hospital (NSTEMI 470/47%, or STEMI 535/53%; N=1005; Gr-L) with similar subset from national databases AMI-PL and PL-ACS (N=117307; NSTEMI 50966/43%, STEMI 64078/57%; Gr-Pol).…

Compliance (physiology)Invasive strategymedicine.medical_specialtybusiness.industrymedicineMyocardial infarctionCardiology and Cardiovascular Medicinemedicine.diseasebusinessIntensive care medicineEuropean Heart Journal
researchProduct

2020

One crucial parameter to evaluate the state of the heart after myocardial infarction (MI) is the viability of the myocardial segment, i.e., if the segment recovers its functionality upon revascularization. MRI performed several minutes after the injection of a contrast agent (delayed enhancement-MRI or DE-MRI) is a method of choice to evaluate the extent of MI, and by extension, to assess viable tissues after an injury. The Emidec dataset is composed of a series of exams with DE-MR images in short axis orientation covering the left ventricle from normal cases or patients with myocardial infarction, with the contouring of the myocardium and diseased areas (if present) from experts in the dom…

Contouringmedicine.medical_specialtyInformation Systems and ManagementShort axisbusiness.industrymedicine.medical_treatmentDelayed enhancementEmergency department030204 cardiovascular system & hematologymedicine.diseaseRevascularization030218 nuclear medicine & medical imagingComputer Science Applications03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureVentriclemedicineSegmentationMyocardial infarctionRadiologybusinessInformation SystemsData
researchProduct

Cardiac threat appraisal and depression after first myocardial infarction

2012

The present study investigated cardiac threat appraisal and its association with depression after first myocardial infarction (MI). A semi-structured interview allowing for DSM-IV-Axis I diagnoses was administered to 36 patients after first MI. Patients completed self-reports 5 to 15 days after the MI (time 1), 6 to 8 weeks later (time 2) and again 6 months later (time 3). Assessments at time 1 included indices of cardiac threat appraisal, locus of control, coping, and depression while at time 2 and time 3 only measures of depression were obtained. Cardiac threat appraisal was significantly correlated with depression at time 1, but was unrelated to depression scores at time 2 and time 3. Fu…

Coping (psychology)medicine.medical_specialtylcsh:BF1-990Myocardial InfarctionIllness AdaptationFirst myocardial infarction: Theoretical & cognitive psychology [H12] [Social & behavioral sciences psychology]: Traitement & psychologie clinique [H13] [Sciences sociales & comportementales psychologie]: Treatment & clinical psychology [H13] [Social & behavioral sciences psychology]Cardiac Threat AppraisalCoping with myocardial infarction: Psychologie animale éthologie & psychobiologie [H01] [Sciences sociales & comportementales psychologie]medicinePsychologyMyocardial infarctionPsychiatryPractical implicationsGeneral PsychologyDepressive symptoms: Psychologie cognitive & théorique [H12] [Sciences sociales & comportementales psychologie]Original Research: Psychiatry [D21] [Human health sciences]: Psychiatrie [D21] [Sciences de la santé humaine]business.industryDepression: Neurosciences & comportement [H07] [Sciences sociales & comportementales psychologie]medicine.diseaseLocus of controllcsh:Psychology: Neurosciences & behavior [H07] [Social & behavioral sciences psychology]: Animal psychology ethology & psychobiology [H01] [Social & behavioral sciences psychology]business
researchProduct